Home/Filings/4/0001384101-22-000157
4//SEC Filing

Kennedy Giulia C 4

Accession 0001384101-22-000157

CIK 0001384101other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 5:18 PM ET

Size

4.7 KB

Accession

0001384101-22-000157

Insider Transaction Report

Form 4
Period: 2022-12-06
Kennedy Giulia C
Chief Scientific & Med Officer
Transactions
  • Sale

    Common Stock

    2022-12-06$27.03/sh1,023$27,65265,970 total
Footnotes (1)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001769333

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:18 PM ET
Size
4.7 KB